HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neutrophil activation via beta2 integrins (CD11/CD18): molecular mechanisms and clinical implications.

Abstract
Polymorphonuclear neutrophils (PMN) are key components of the innate immunity and their efficient recruitment to the sites of lesion is a prerequisite for acute inflammation. Signaling via adhesion molecules of the beta2 integrin family (CD11/CD18) plays an essential role for PMN recruitment and activation during inflammation. In this review, we will focus on the non-receptor tyrosine kinase Syk, an important downstream signaling component of beta2 integrins that is required for the control of different PMN functions including adhesion, migration and phagocytosis. The exploration of beta2 integrin-mediated Syk activation provided not only novel insights into the control of PMN functions but also led to the identification of Syk as a new molecular target for therapeutic intervention during inflammatory diseases.
AuthorsJürgen Schymeinsky, Attila Mócsai, Barbara Walzog
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 98 Issue 2 Pg. 262-73 (Aug 2007) ISSN: 0340-6245 [Print] Germany
PMID17721605 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • CD11 Antigens
  • CD18 Antigens
  • Intracellular Signaling Peptides and Proteins
  • Protein-Tyrosine Kinases
  • SYK protein, human
  • Syk Kinase
Topics
  • CD11 Antigens (physiology)
  • CD18 Antigens (physiology)
  • Humans
  • Inflammation
  • Intracellular Signaling Peptides and Proteins (metabolism)
  • Neutrophil Activation
  • Neutrophil Infiltration
  • Protein-Tyrosine Kinases (metabolism)
  • Signal Transduction
  • Syk Kinase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: